Clinical trial
Identifying Methylation Biomarkers for Monitoring Bladder Tumors
NCT00244205 · Copenhagen University Hospital at Herlev, Other · Unknown status
Key facts
| NCT number | NCT00244205 |
|---|---|
| Title | Identifying Methylation Biomarkers for Monitoring Bladder Tumors |
| Official title | Using PCR Technology (Polymerase Chain Reaction Technology) for Monitoring Patients With Bladder Tumors - Optimizing Genanalyses for Clinical Use. |
| Lead sponsor | Copenhagen University Hospital at Herlev, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Bladder Cancer |
| Intervention type | Procedure |
| Interventions | Identifying genes methylated in urine |
| Enrollment | 120 |
| Start date | Nov 1, 2005 |
| First posted | Oct 26, 2005 |
| Last update posted | Nov 15, 2005 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: